Aptose Biosciences (TSE:APS) Stock Price Crosses Below 200-Day Moving Average – Time to Sell?

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$9.25 and traded as low as C$2.75. Aptose Biosciences shares last traded at C$2.77, with a volume of 3,601 shares trading hands.

Analyst Ratings Changes

Separately, Alliance Global Partners raised Aptose Biosciences to a “strong-buy” rating in a report on Thursday, February 27th.

Aptose Biosciences Trading Up 19.1 %

The stock has a market cap of C$142.09 million, a P/E ratio of -0.66 and a beta of 1.36. The company has a debt-to-equity ratio of -117.37, a quick ratio of 5.41 and a current ratio of 1.05. The company has a 50-day simple moving average of C$4.97 and a 200-day simple moving average of C$9.21.

Aptose Biosciences Company Profile

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.